Lowenstein Sandler represented Recess, the category pioneer and leader of the relaxation beverage space, in the closing of its Series B funding round of $30 million.
The round—led by CAVU Consumer Partners, with participation from Rocana, Midnight Ventures, Torch Capital, Doehler Ventures, KAS Venture Partners, Vanquish, and Craig Kallman—will enable the company to invest in scaling its organization, support retail expansion, and increase its marketing efforts to drive accelerated growth in the years to come.
The combination of CAVU’s investment and the addition of Kyle Thomas, former Nutrabolt Global Chief Commercial Officer, as President & Co-CEO, speak to the strong performance of the Recess brand platform, as well as the significant opportunity that lies ahead for Recess to scale as a result of the growing consumer demand for products that enhance mental wellness, support relaxation and stress relief, enable alcohol moderation, and improve sleep.
Recess launched in late 2018 as the pioneer CBD beverage but has since expanded significantly beyond its original product line. Recess is currently sold in over 15,000 stores across the country including Target, HEB, Kroger, Sprouts, Trader Joes, and Whole Foods; and is also the largest alcohol alternative brand on Amazon.
The Lowenstein team included Eric Weiner, Frank W. Eucalitto, Claire Dronzek, Dylan Blanchard, and Eric Sands.
